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Abstract
Gene Ontology (GO) provides dynamic controlled vocabularies to aid in the description of the functional biological
attributes and subcellular locations of gene products from all taxonomic groups (www.geneontology.org). Here we describe
collaboration between the renal biomedical research community and the GO Consortium to improve the quality and
quantity of GO terms describing renal development. In the associated annotation activity, the new and revised terms were
associated with gene products involved in renal development and function. This project resulted in a total of 522 GO terms
being added to the ontology and the creation of approximately 9,600 kidney-related GO term associations to 940 UniProt
Knowledgebase (UniProtKB) entries, covering 66 taxonomic groups. We demonstrate the impact of these improvements on
the interpretation of GO term analyses performed on genes differentially expressed in kidney glomeruli affected by diabetic
nephropathy. In summary, we have produced a resource that can be utilized in the interpretation of data from small- and
large-scale experiments investigating molecular mechanisms of kidney function and development and thereby help
towards alleviating renal disease.
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Introduction
All complex organisms require the ability to balance fluids and
excrete toxic metabolic byproducts. Renal systems achieve this by
filtering and excreting substances using specialized cells, tissues
and organs. As researchers have embraced proteomic and
genomic investigative methods to identify, quantify and charac-
terize pathways and networks associated with the renal system
over the past decade, a wealth of biological information has
resulted [1–8]. This data deluge is often time-consuming for
researchers to analyse, and highlights the need for a representation
of renal biology that enables high-quality, detailed, computational
analysis. Given that renal researchers make extensive use of model
organisms, such a resource needs to take account of the similarities
and differences between species in order to provide a species-
neutral representation of development and allow for cross-species
comparison. Although the renal system is generally composed of
tubules that transport water and solutes between an organism and
its external environment, the system structure differs across
species. In insects, and some other classes, the renal system is
comprised of Malpighian tubules, whereas in vertebrates and some
invertebrates it is made up of several organs, with the kidney being
the main player in fluid and solute exchange. While renal systems
differ in structure throughout the animal kingdom, there are
necessary physiological similarities [9]. These physiological pro-
cesses must be represented in a general way to allow effective
comparisons between species. In addition, the resource needs to
provide for the nomenclature differences that arise. Even with the
existence of a standard nomenclature for structures of the kidney
proposed by the Renal Commission of the International Union of
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Physiological Sciences [10] and a high-resolution ontology to
describe the sub-compartments of the developing murine genito-
urinary tract developed by the GUDMAP Consortium [11], there
is still linguistic ambiguity amongst the renal community regarding
the naming of processes associated with the function and
development of the renal system. For example, ‘nephrogenesis’ is
used by some to refer to the process of overall kidney development,
but is also commonly used to describe the formation of the
individual functioning nephrons within the kidney.
The Gene Ontology (GO) project aims to provide a structured
vocabulary that can be used to annotate gene products from any
species in the context of their role within an organism and their
location within a cell or in the vicinity of a cell. We embarked on a
project to improve the way in which GO describes the processes of
renal development and physiology [12]. GO terms referencing
renal anatomical structures were made consistent with existing
resources including the GUDMAP Consortium [8], the Cell Type
Ontology [13] and the multi-species Uber anatomy ontology
(UBERON) [14]. Additionally, cross-references [15] were created
between renal system processes in GO and anatomical structures
in UBERON. In doing so, we provide a framework wherein
additional renal-related terms may be added in the future.
To utilize the expanded ontology, renal- and non renal-related
GO terms were associated with gene products involved in renal
development. These annotations were established initially through
the process of manual curation, in which a curator reviewed the
primary literature for experimental evidence to create a gene
product-GO association (annotation). Secondly, where appropri-
ate, these experimentally inferred annotations were transferred to
equivalent gene products in other species [16–18]. This transfer
was performed both manually, by a curator following a BLAST
sequence similarity search [19] and electronically, via the Ensembl
Compara automatic annotation pipeline [20]. Finally, we dem-
onstrate the benefits of the improved ontology and annotations for
a set of genes differentially expressed in kidney glomeruli affected
by the later stages of the disease diabetic nephropathy (DN).
Methods
Ontology Development and Annotation
A meeting was held between renal biomedical experts, GO
curators and GO editors to determine the correct representation of
renal processes (renal development in particular) in the Gene
Ontology. Ontology editors added the new terms and reorganized
existing renal GO terms accordingly.
For annotation purposes, expression data from the GUDMAP
database [8] was used to identify 29 mouse genes expressed in the
murine loop of Henle. BLAST [19] was used to identify similar
genes, where present, in human, zebrafish, Xenopus, chicken and
fly. Table 1 lists the UniProtKB accession numbers of the
corresponding gene products. Curators from UniProt, Mouse
Genome Informatics (MGI), FlyBase and the zebrafish model
organism database (ZFIN) [21–24] then assigned molecular
function, biological process and cellular component GO terms to
the gene products, based on experimental evidence in scientific
papers.
Experimentally assigned GO annotations were subsequently
transferred to proteins in other species that are similar in sequence;
this was performed both manually and electronically. Manually,
curators or authors identified the similar targets via sequence
similarity search programs such as BLAST [19] or Homologene
[25]. Electronically, the experimental annotations acted as a
source of projected annotations for orthologous proteins in
vertebrate species via the Ensembl Compara automatic annotation
pipeline [20].
GO Term Enrichment Analysis
Two term enrichment tools were used for the analyses; GO-
Elite (http://www.genmapp.org/go_elite/) [26,27] and Ontologi-
zer (http://compbio.charite.de/index.php/ontologizer2.html)
[28]; GO term enrichment analysis was performed using
annotations to biological process terms only.
We took the gene data set for our reanalysis from the
investigation into the differential gene expression in glomeruli
from human kidneys with diabetic nephropathy by Baelde et al.
[29]. The gene identifiers used in this 2004 study were mapped to
current UniProtKB accession numbers (Table S1 in File S1). Some
of the gene identifiers, for example, D87002, mapped to multiple
UniProtKB accessions (Q14390, Q5NV78, Q5NV77) because
both ‘reviewed’ and ‘un-reviewed’ sequences in the UniProtKB
database cross-referenced to the same gene identifier. However, in
such cases only one of the accession numbers for the gene product
was curated; usually the reviewed UniProtKB/SwissProt entry or,
if all entries were un-reviewed, the longest UniProtKB/TrEMBL
sequence. The protein accessions in Table S1, in File S1,
constitute the ‘Input’ list for the GO term enrichment analysis.
For the GO-Elite analysis, we used the ORA-pruned analysis
with a z-score cut-off of .1.96, the minimum number of changed
genes was set at 3 and the permuted p-value cut-off was ,0.1.
GO-Elite uses the Z-score/hypergeometric statistical method and
Benjamini-Hochberg (BH) correction for multiple hypothesis
testing [27].
For the Ontologizer analysis, term enrichment was calculated
using the parent-child intersection analysis method using a
modified Fisher’s exact analysis. The single-step minP procedure
of Westfall-Young was applied as a multiple testing correction.
Terms were considered significantly enriched if the adjusted p-
value was ,0.1 [28].
Data Files
Ontology files were downloaded from: http://cvsweb.
geneontology.org/cgi-bin/cvsweb.cgi/go/ontology/
gene_ontology.obo.
Versions of the ontology files downloaded from the above
location, used in OBO-Edit for creating Figure 1, were from
November 18th 2009 and those for creating Figures 2, 3 and 4
were from March 19th 2012.
Gene Association Files (GO annotation datasets) were down-
loaded from ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/old/
HUMAN/and ftp://ftp.ebi.ac.uk/pub/contrib/goa/
ReferenceGenome/20120319/.
File versions used for the 2012, ‘post-annotation dataset’
analysis reported in Tables S2–S9 in File S1 and Tables 2 and 3
were Gene Ontology revision 4.1180 (March 20th 2012) and
annotation file ‘gene_association.goa_human.gz’ (March 19th
2012).
File versions used for the 2009, ‘pre-annotation dataset’ analysis
reported in Tables S2–S9 in File S1 and Table 3, were Gene
Ontology revision 4.548 (March 5th 2009) and annotation file
‘gene_association.goa_human.72.gz’ (March 5th 2009).
The ‘Background’ list of protein accessions used in the GO term
enrichment analyses was obtained from the relevant Gene
Association File. For example, the background list for the 2009
analyses was the unique protein accessions in the ‘gene_associa-
tion.goa_human.72.gz’ file.
Annotation data sets for renal specific gene products and GO
terms can be viewed via the QuickGO browser at www.ebi.ac.uk/
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QuickGO, using either gene product name(s), UniProtKB
accession number(s) or GO term(s).
Results and Discussion
The renal system development node of the GO has been
expanded and refined in response to a common need for a
computational resource for investigators in this field. The GO
Consortium has previously demonstrated success in developing a
specific area of the ontology through focus meetings where
community experts meet alongside ontology developers to discuss
the current knowledge of the biological area of interest and its best
representation in the GO [30,31]. Therefore, this approach was
also used in the refinement of renal system development
representation in the GO.
Enhancement of the Gene Ontology for Renal
Development
By consulting with renal experts, we have extensively improved
the renal development branch of the GO. Prior to this project, the
GO contained only 21 terms to describe renal development; 18
terms under and including ‘kidney development’ (GO:0001822) and 3
terms describing development of the insect renal system, the
Malpighian tubule (Figure 1). Ultimately this project has resulted
in an additional 522 renal development GO terms, including 137
under ‘metanephros development’ (GO:0001656), 102 terms under
‘mesonephros development’ (GO:0001823), 28 terms under ‘pronephros
development’ (GO:0048793) and 19 terms under ‘Malpighian tubule
development’ (GO:0072002). Figure 2 displays an OBO-Edit
Ontology Tree Editor view of a subset of the expanded
pronephros development GO terms. Definitions and synonyms
of existing terms were also improved. For example, the ambiguity
of the word ‘nephrogenesis’ has been addressed by including it as a
Table 1. UniProtKB accession numbers for 29 homologous proteins using data from in-situ hybridisation expression in murine
loop of Henle.
UniProtKB accession number
Protein name Mouse Human Rat Chicken Xenopus laevis/tropicalis Drosophila melanogaster
Tesc Q9JKL5 Q96BS2 D3ZTN19 A0AVX7 Q5U554/Q0V9B1 n/a
Slc23a1 Q9Z2J0 Q9UHI7 Q9WTW7 B9VMA9 -/B0JZG0 (Q9VH02)
Ctnnb1 Q02248 P35222 Q9WU82 O42486 P26233/Q28GC2 P18824
Lamb1-1 P02469 P07942 P15800 O57484 Q5XHI6/B3DLV1 (P11046)
Egr1 P08046 P18146 P08154 O73691 Q6GQH4/A4II20 n/a
Pou3f3 (Brn1) P31361 P20264 Q63262 Q52HB4 O73861 P70030/A1L0Z1 (P16241)
Id2 P41136 Q02363 P41137 O73933 Q9YGL0/Q6PBD7 n/a
Cdh11 P55288 P55287 Q9JIW2 O93319 O93264/Q5EAM2 n/a
Aldh1l1 Q8R0Y6 O75891 P28037 O93344 Q6GNL7/Q63ZT8 (Q9VIC9)
Tfap2b Q61313 Q92481 P58197 O93346 Q66J14/Q28C75 n/a
Ttr P07309 P02766 P02767 P27731 Q9W649/A4QNN7 n/a
Ptn P63089 P21246 P63090 P32760 P48532/A4IH83 n/a
Ccnd1 P25322 P24385 P39948 P55169 P50755/Q6GLD3 n/a
Irx3 P81067 P78415 n/a Q9PUR3 O42261/Q6NVN3 n/a
Irx2 P81066 Q9BZI1 n/a Q9PU52 Q6DCQ1/Q66IK1 n/a
Irx1 P81068 P78414 n/a Q9I9C5 Q9YGK8/Q6F2E3 n/a
Pax2 P32114 Q02962 D4ACZ2 Q9PTX1 O57685 O57682/Q28IR6 n/a
Pax8 Q00288 Q06710 P51974 n/a Q9PUK5/A0JMA6 n/a
Bmp4 P21275 P12644 Q06826 Q90752 P30885/Q90YD6 n/a
Cited1 P97769 Q99966 Q4V8P1 n/a n/a n/a
Cited2 O35740 Q99967 Q99MA1 Q9DDW4 Q5XGW7/Q6NX30 Q28GT4 n/a
c-myc P01108 P01106 P094169 P01109 P06171/Q6P1T1 n/a
WT1 P22561 P19544 P49952 Q9I8A0 Q9I8A1 B7ZSG3 P79958/B5DE03 n/a
Osr1/Odd1 Q9WVG7 Q8TAX0 B0K011 E1BWE8 P86413/Q66JF8 P23803
Osr2 Q91ZD1 Q8N2R0 Q6AY34 E1BUP0 Q32NK7 Q0IHB8/2 Q9VQS7
PDGFRB P05622 P09619 Q05030 n/a n/a n/a
PDGFRA P26618 P16234 P20786 Q9PUF6 P26619/A4IHL2 n/a
PDGFB P31240 P01127 Q05028 Q90W23 Q6DDJ9/B1H1E3 B0BM23 n/a
PDGFA P20033 P04085 P28576 Q90WK2 Q9PUF7 P13698/B0BM23 (Q9VWP6)
Uniprot accession numbers are listed for homologues of the 29 proteins expressed in the murine loop of Henle structure (data provided by the GUDMAP Consortium via
www.gudmap.org) as determined by BLAST (run via the uniprot.org website). The Drosophila proteins in parentheses are homologous to multiple mammalian proteins.
(n/a = not applicable).
doi:10.1371/journal.pone.0099864.t001
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Figure 1. An OBO-Edit ‘Ontology Tree Editor’ view showing the 21 Gene Ontology terms representing renal development before
the expansion in this area of the ontology. There were 18 GO terms directly under the ‘kidney development’ node and 3 terms representing
morphogenesis of the insect renal system, the Malpighian tubule (using the Gene Ontology file from November 18th 2009). The [2] icon beside each
term denotes no further child terms; (P) denotes a part_of relationship; (I) denotes an is_a relationship.
doi:10.1371/journal.pone.0099864.g001
Figure 2. An OBO-Edit ‘Ontology Tree Editor’ view demonstrating the improved Gene Ontology representing ‘kidney
development’ after a focused expansion. The Gene Ontology representing kidney development was enriched after a focused expansion
with an additional 522 new terms, and as an example (using the Gene Ontology file from March 19th 2012) the expanded node of the ‘pronephros
development’ term shows it’s immediate child terms. The [+] icon beside each term denotes that there are further child terms that can be viewed; the
[2] icon denotes no further child terms; (P) denotes a part_of relationship; (I) denotes an is_a relationship; (R) denotes a regulates relationship.
doi:10.1371/journal.pone.0099864.g002
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synonym for both ‘kidney development’ (GO:0001822) and ‘nephron
development’ (GO:0072006), enabling curators to make a decision on
which term to choose depending on the evidence they are
presented with.
We have made use of existing renal cell and anatomy resources
and have ensured that GO terms referencing such structures are
also made consistent with those described by the GUDMAP
Consortium [8] and the Cell Type Ontology [13]. For example, in
creating the new GO term ‘nephrocyte diaphragm assembly’
Figure 3. An OBO-Edit ‘Ontology Tree Editor’ view representing similarities in tubule structures and grouped terms describing the
development of different types of renal tubules. Similarities are observed in GO terms representing tubule structures and terms are grouped
together describing the development of different types of renal tubules including the Malpighian tubule of insects (using the Gene Ontology file
from March 19th 2012). The [+] icon beside a term denotes that the node is expandable and has further child/grandchild terms; the [2] icon denotes
no further child terms; (P) denotes a part_of relationship; (I) denotes an is_a relationship.
doi:10.1371/journal.pone.0099864.g003
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(GO:0036059) we have utilized the cell type ontology term
‘nephrocyte’ (CL:0002520). In addition, we extended UBERON [14]
to include all the renal structures named within GO terms, and
also created cross-references [15] between renal system processes
Figure 4. An OBO-Edit ‘Ontology Tree Editor’ view showing the relationship and position of the new GO term ‘branching involved in
ureteric bud morphogenesis’. By placing the new term ‘branching involved in ureteric bud morphogenesis’ as a sub-type of ‘morphogenesis of a
branching structure’, it puts the renal branching into the context of other types of branching morphogenesis within the Gene Ontology (using the
Gene Ontology file from March 19th 2012). The [+] icon beside each term denotes that there are further child terms that can be viewed; the [2] icon
denotes no further child terms; (P) denotes a part_of relationship; (I) denotes an is_a relationship.
doi:10.1371/journal.pone.0099864.g004
Table 2. Summary of the number of GO terms significantly enriched in the differentially expressed gene dataset from glomeruli
affected by Diabetic Nephropathy (DN) by both Ontologizer and GO-Elite enrichment analysis tools.
Gene set Number of significantly enriched GO terms (p,0.1)
pre-annotation post-annotation
Ontologizer GO-Elite Ontologizer GO-Elite
Up-regulated 42 22 182 139
Down-regulated 48 21 127 85
A summary of the number of GO terms that were significantly enriched (having a p-value of ,0.1) in the Baelde groups’ differentially expressed gene dataset from
glomeruli affected by DN [29] by both Ontologizer [28] and GO-Elite [27] term enrichment tools, using the pre-annotation (2009) and post-annotation (2012) GO
annotation datasets.
doi:10.1371/journal.pone.0099864.t002
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in GO and anatomical structures in UBERON. For example, the
term ‘metanephric mesenchymal cell proliferation involved in metanephros
development’ (GO:0072136) is cross-referenced in UBERON to
‘metanephric mesenchyme’ (UBERON:0003220) and ‘metanephros’
(UBERON:0000081).
Representing Anatomical Groupings
We present a framework for the future addition of renal-related
ontology terms as knowledge of renal development progresses.
This required the careful construction of relationships between the
GO terms to place them in context with other cellular and
developmental GO processes. One particularly interesting chal-
lenge was representing development of renal structures so they
could be described as individual structures but also grouped for the
purpose of data aggregation. For example, the term ‘renal tubule’
specifies a particular anatomical structure in a renal system and
differentiates it from other biological tubules.
The first task was to define a renal system in the context of GO
terms. In consultation with the renal experts, we defined ‘renal
system’ as ‘a system that maintains fluid balance and contributes to electrolyte
balance, acid/base balance and disposal of nitrogenous waste products’ (see
GO:0003014 ‘renal system process’). This definition is inclusive of the
organs of the vertebrate renal system, as well as the Malpighian
tubules of insects, and allows for future incorporation of structures
such as the antennal glands of crustaceans. The term ‘kidney
development’ (GO:0001822) is used to cover the development of the
three vertebrate structures; the pronephros, the mesonephros and
the metanephros. As these structures all contain tubules that
function in the renal system, terms describing the development of
each type of renal tubule, such as ‘Malpighian tubule development’
(GO:0072002) and ‘nephron tubule development’ (GO:0072080) are
grouped together under a ‘renal tubule development’ (GO:0061326)
term (Figure 3). This type of anatomical grouping affords another
benefit in allowing comparison of gene products involved in renal
tube development with those involved in tube development in
other systems including the respiratory system, circulatory system,
digestive system and the early embryo. Such comparisons can be
used to elucidate common molecular strategies in the development
of epithelial tubes.
Representing Similar Developmental Processes
A critical aspect in understanding the development of a
structure is the identification of similar molecular mechanisms
that are used repeatedly across development. Grouping renal
system processes in the GO with similar processes in other organs
can enable the user to predict gene products that may play an
important role in renal system development. In the GO,
developmental processes are broken down into several categories:
morphogenetic mechanisms that shape a structure, signaling
mechanisms that allow cells and tissues to communicate, pattern
specification mechanisms that lay out the landscape in which cells
differentiate, and gene regulatory mechanisms that permit the
correct expression of sets of genes responsible for cell differenti-
ation.
Thus we have created terms that describe the morphogenesis of
tubes, epithelia and mesenchymal tissues with respect to specific
renal structures. For example, ‘epithelial cell proliferation involved in
renal tubule morphogenesis’ (GO:2001013) and ‘mesenchymal to epithelial
transition involved in metanephric renal vesicle formation’ (GO:0072285).
Moreover, by placing the term ‘branching involved in ureteric bud
morphogenesis’ (GO:0001658) as a sub-type of ‘morphogenesis of a
branching structure’ (GO:0001763), renal branching is put into the
context of other types of branching morphogenesis in GO
(Figure 4).
We have also created terms to describe known inductive events
involved in the initial formation of renal structures such as
‘specification of metanephric proximal tubule identity’ (GO:0072297) and
‘anterior/posterior pattern specification involved in pronephros development’
(GO:0034672).
Use of the New Renal Development GO Terms in Gene
Product Annotation
Following the improved ontology structure for renal system
development, curators annotated renal-related gene products. The
first annotation targets were the 29 gene products highly expressed
in the mouse loop of Henle [8] and hence predicted to play a role
in the development and/or physiology of this renal structure. To
compare the function of these proteins across species, similar
proteins in human, rat, zebrafish, Drosophila and Xenopus (found via
BLAST run on the uniprot.org website) were also annotated.
Table 3. Summary of significantly enriched GO terms from the Ontologizer and GO-Elite analyses that are relevant to kidney
development.
GO ID GO Term Name
Observed in
Ontologizer (O);
GO-Elite (G)
Rank 2012 n=127
(O), n= 85 (G)
Rank 2009
n=48 (O),
n =21 (G)
GO:0032835 glomerulus development G 1 n/a
GO:0061005 cell differentiation involved in kidney development G 2 n/a
GO:0001655 urogenital system development O 10 14
.GO:2001012 mesenchymal cell differentiation involved in renal system development O 90 n/a
.GO:0001657 ureteric bud development O 65 n/a
GO:0003014 renal system process O, G 52(O); 25(G) n/a
.GO:0097205 renal filtration O 43 n/a
GO:0001763 morphogenesis of a branching structure O 64 42
.GO:0048754 branching morphogenesis of an epithelial tube G 43 n/a
A summary of the significantly enriched GO terms from the Ontologizer [28] and GO-Elite [27] analyses, which are relevant to kidney development, using the pre-
annotation (2009; Tables S2–S5 in File S1) and post-annotation datasets (2012; Tables S6–S9, in File S1). Terms in italics indicate parent terms where the descendants are
indicated directly underneath as follows: . descendant of term above in italics. Rank refers to the position of the term in the results of the enrichment analyses (see
Tables S2–S9 in File S1) where significance of the enriched term has a p-value of ,0.1. (n/a = not applicable).
doi:10.1371/journal.pone.0099864.t003
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Table 1 lists the UniProtKB accession numbers for these gene
products. The loop of Henle plays an important role in creating a
concentration gradient in the medulla of the kidney. It is involved
in reabsorption of filtered water and ions including sodium,
potassium and calcium, and independently regulates both the
volume and osmolarity of body fluids. The structure differs
considerably between species; there is a definite physical loop of
Henle in the mammalian and avian renal systems but this seems to
be absent in Xenopus. However, homologs of some, but not all,
molecular markers (e.g. cldn8 and clcnk) of the mammalian loop of
Henle were found to be present in the pronephros of the frog larva
[32]. Therefore, annotation of gene products expressed in the loop
of Henle structure could provide an insight into how the functions
of gene products have evolved. For Drosophila, where similar
proteins for this set of target proteins were unclear, we attempted
to make annotations with all of the 19 new terms that were created
to describe Malpighian tubule development; 82 new manual
annotations were added for Drosophila melanogaster using these terms
alone (see section ‘‘Comparison of Renal GO Annotations Across Species’’).
An additional aim of this curation project was to curate the
biological roles of human proteins encoded by RNAs previously
identified as being differentially expressed in kidney glomeruli
affected by late stage diabetic nephropathy (DN) [29] (Table S1 in
File S1). The effect of this focused annotation is reported in the
later section ‘‘Impact of improved Gene Ontology annotation on data
analysis’’.
Although the focus of this project is renal development, this
initiative has also expanded curation of the renal physiology and
function nodes of GO. Annotations have been made using GO
terms that describe aspects of renal processes such as acid-base
homeostasis, transmembrane ion (e.g. sodium, potassium ion)
transport, renal water homeostasis, renal absorption, renal
secretion, blood pressure regulation and regulation of urine
volume. It should also be noted that improvements to annotations
of renal-specific gene products and to the Gene Ontology
representing renal processes are an ongoing task, as more
biomedical research is published, identifying the role of various
existing and newly identified gene products in renal function and
development.
In total, this project has manually assigned approximately 9,600
kidney-related GO annotations to 940 distinct UniProtKB protein
entries across 66 species and has greatly improved the number and
quality of annotations associated with individual proteins. This
manual annotation application also benefits orthologous proteins
in other species by virtue of the automatic annotation created by
Ensembl Compara [20], which projects experimental GO
annotation between similar vertebrate species (50,000 electronic
annotations were created for over 2,500 UniProtKB entries
covering 32 taxa).
The initiative has expanded and improved GO annotation for
gene products, as demonstrated by the mouse PAX8 protein
(UniProtKB:Q00288). Prior to the start of the annotation project,
this protein had been associated with a single renal GO term,
‘metanephros development’ (GO:0001656). After the focused effort
however, it had an extra 32 GO annotations, containing 17 unique
renal development terms. The annotation has also introduced
more specificity, with terms such as ‘negative regulation of mesenchymal
stem cell apoptotic process involved in metanephric nephron morphogenesis’
(GO:0072305) and ‘metanephric distal convoluted tubule development’
(GO:0072221). The focused annotation of this protein has brought
together data from 15 published papers and highlighted the
additional involvement of PAX8 in non-renal developmental
processes such as ‘inner ear morphogenesis’ (GO:0042472) and ‘thyroid
gland development’ (GO:0030878), thus emphasizing the importance
of manual curation for capturing all functional roles of a gene
product.
Comparison of Renal GO Annotations Across Species
The species-neutral nature of GO makes it a powerful tool for
cross-species use with the potential to highlight common
mechanisms governing renal development. It is unsurprising that
GO annotations point to a similar role of renal gene products
between human, rat and mouse, but perhaps more interesting is
where the similarity of gene roles extends beyond the mammals to
frog and fish, and in some cases to fly.
The transcription factors HEY1 and HEYL, LHX1, MECOM,
TCF21, WT1 and the Odd-skipped-, PAX- and SOX-family
members all have renal GO annotations in multiple species. The
Odd-skipped family of proteins (Odd in Drosophila and OSR1 and
OSR2 in vertebrates) has annotations to renal system development
terms in fly (‘Malpighian tubule morphogenesis’ (GO:0007443)), across
fish and frogs (‘pronephros development’ (GO:0048793)), up to
mammals (‘mesonephros development’ (GO:0001823) and ‘metanephros
development’ (GO:0001656)). OSR1 annotations are more detailed
than those for OSR2, given that there is experimental evidence for
OSR1 being the earliest marker for intermediated mesoderm, the
precursor to the mammalian metanephric kidney [33]. Annota-
tions to OSR2 are more general as they have been assigned from
expression patterns and include the terms ‘metanephros development’
(GO:0001656) and ‘mesonephros development’ (GO:0001823). This
may reflect the fact that the role of OSR2 in mammalian kidney
development is less clear than for OSR1, or that despite renal
expression patterns, mouse OSR2 may not be required for mouse
kidney development [34]. Conversely, in Xenopus and zebrafish
both Osr1 and Osr2 have been demonstrated to have essential
roles in pronephros development [35].
The PAX transcription factors are similarly known to be
important regulators of kidney development [36], with PAX2
defects resulting in renal diseases including renal hypodysplasia
[37]. GO annotations in organisms including Xenopus, zebrafish,
mouse and human confirm a role for the PAX2 and PAX8
transcription factors in processes including ‘pronephric field specifica-
tion’ (GO:0039003) [38], ‘regulation of kidney size’ (GO:0035564) [39]
and ‘branching involved in ureteric bud morphogenesis’ (GO:0001658)
[40].
The ‘NOT’ qualifier has proven useful in the renal annotation
of members of Iroquois protein family. GO annotations point to at
least the IRX3 transcription factor being involved in directing
nephron identity. Xenopus laevis Irx1-a and Irx3 are annotated to
‘specification of pronephric tubule identity’ (GO:0039005) [41,42] whilst
mouse IRX2 and IRX3 have annotations to ‘specification of loop of
Henle identity’ (GO:0072086) [42]. With the ‘NOT’ qualifier in
place, annotations to Xenopus Irx4-A and Irx5 proteins state that
these family members do not have a role in frog pronephros
development, thus indicating divergence in the functions of this
protein family.
Many signaling cascades trigger the activation of transcription
factors and we identify signaling pathways involved in the
development of renal tubules in multiple species. GO annotations
point to a role for WNT family members in renal development;
Drosophila Wingless (Wg) has Malpighian tubule GO annotations,
with renal annotations continuing for vertebrate WNT proteins,
most notably ‘ureteric bud development’ (GO:0001657) in human and
mouse, and ‘glomus development’ (GO;0072013) in Xenopus. Thus,
despite the morphological differences in kidney structure between
organisms as diverse as frogs and humans, the nephron units show
similar functions and the genes regulating development of these
units show functional similarities.
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Members of the bone morphogenetic protein (BMP) family are
important signaling molecules, and GO annotations point to a
critical role for BMP signaling in the development of renal
structures across species. Sonic hedgehog (SHH) and its receptor,
PATCHED (PTCH1) have annotations to broad kidney develop-
ment terms, from fish to mouse and human. Drosophila Decapen-
taplegic (Dpp), together with the intracellular SMAD proteins
Mothers against Dpp (Mad) and Daughters against Dpp (Dad, an
inhibitory SMAD) all have annotations to ‘BMP signaling pathway
involved in Malpighian tubule cell chemotaxis’ (GO:0061353) and related
terms. Similarly, in vertebrates including chicken, mouse and
human, BMP2 and BMP4 proteins have annotations to a range of
kidney development terms including ‘ureteric bud development’
(GO:0001657) and ‘ureter epithelial cell differentiation’ (GO:0072192).
Other members of the BMP signaling pathway also show renal
annotations. The secreted Dpp/BMP-inhibitors Short gastrulation
(Sog) in Drosophila and Chordin in Xenopus, have annotations to
‘posterior Malpighian tubule development’ (GO:0061328) and ‘pronephros
development’ (GO:0048793), respectively. Likewise, the BMP antag-
onist GREM1 shows ‘pronephros development’ (GO:0048793) anno-
tations in Xenopus and ‘ureteric bud morphogenesis’ (GO:0060675) and
‘metanephros morphogenesis’ (GO:0003338) annotations in mouse, thus
providing further hints for a comparable BMP signaling pathway
in renal tubule development across species.
In summary, this annotation exercise reveals interesting
comparisons of renal development across species and has
confirmed that although the kidney structures themselves differ
between insects, non-mammalian vertebrates and mammals, some
of the associated gene products and pathways show similar roles in
renal development.
Impact of Improved Gene Ontology Annotation on Data
Analysis
To test the value of increasing the depth and coverage of GO
annotation for renal-related proteins on interpretation of exper-
iments, we compared the annotation dataset from immediately
prior to our focused annotation project (March 2009, and referred
to hereafter as the ‘pre-annotation dataset’) with the dataset from
the end of the project (March 2012, and referred to hereafter as
the ‘post-annotation dataset’). To this end, we fully annotated the
biological roles of a set of human proteins that were initially
identified in a study of genes differentially expressed in glomeruli
of kidneys affected by the later stages of diabetic nephropathy
(DN), as reported by Baelde et al. [29]. We chose to test the
improvement in the annotation dataset by performing a term
enrichment analysis on the differentially expressed gene products
identified in the original study, as this is an efficient way to get an
overview of the annotations for a set of genes without losing the
specificity of the added GO terms, and can be used to directly
compare the results obtained by Baelde et al. [29] in their original
analysis.
DN is characterized by increased levels of albumin in the urine
(albuminuria) associated with a combination of altered glomerular
hemodynamics and a thickened glomerular basement membrane.
In the early stages of DN there is a phase of overgrowth caused by
angiogenesis and endothelial hyperproliferation, which results in a
corresponding increase in the glomerular filtration rate. This is
followed, in the later stages, by capillary loss and fibrosis,
progressing to renal failure. Hence, processes involved in the
progression of DN include altered endothelial cell turnover [43–
45], epithelial-to-mesenchymal transition involving the cytokine
transforming growth factor-beta1 (TGFb1) [46] and altered
vascular growth factor signaling [47]. The diabetic kidneys used
by Baelde et al. [29] contained ‘‘nodular glomerulosclerosis and
arteriolar hyalinosis’’, hence they were in the later stages of the
disease.
Baelde et al. [29] performed term enrichment analysis on the
identified up- and down-regulated genes and reported the
appearance of GO terms that are noticeably high-level, less-
specific terms such as ‘intracellular signaling transduction’
(GO:0035556), ‘negative regulation of cell proliferation’ (GO:0008285),
‘homeostatic process’ (GO:0042592) and ‘nucleobase-containing compound
metabolic process’ (GO:0006139). Unfortunately, these types of terms
convey little information about the specific role of a gene product
in DN and there was evidence that the gene products were lacking
sufficient functional annotation. The GO term enrichment
analysis reported by Baelde et al. in 2004 [29] was performed
using MappFinder [26], however this is no longer supported, so we
used its sister tool, GO-Elite [27] to perform the reanalysis of the
datasets. In a previous study [48], we demonstrated the need to use
a variety of GO analysis tools to ensure a balanced interpretation
of the dataset, therefore we also used Ontologizer [28].
Overall Observations from the Analysis
The analysis was performed separately on up- and down-
regulated genes since this distinction was made in the original
analysis [29]. Full term enrichment results for both up- and down-
regulated genes using both GO-Elite and Ontologizer are
available as Tables S2–S9 in File S1.
Table 2 summarizes the number of terms significantly enriched
by both Ontologizer and GO-Elite term enrichment tools using
the GO annotation datasets from before and after the annotation
focus. The most striking observation is that, in the output from
both tools, there are significantly more enriched terms using the
post-annotation dataset, compared to using the pre-annotation
dataset (significance cut-off values are reported in the ‘Methods’
section). In general, the terms that were significantly enriched
using the post-annotation dataset were not enriched using the pre-
annotation dataset, indicating that focused GO annotation using
both existing and the new terms created during this initiative has
had a great impact on the interpretation of this analysis.
Enrichment of terms related to kidney development. A
significant observation from our analysis was the appearance of
some of the new renal development GO terms created by our
ontology improvements, summarized in Table 3. For example,
‘mesenchymal cell differentiation involved in renal system development’
(GO:2001012) (Table S9 in File S1) and ‘cell differentiation involved
in kidney development’ (GO:0061005) (Table S8 in File S1). The
impact of the focused annotation was also recognized by the
appearance of some older terms that were available at the time of
the original 2004 study, but which had not been associated with
the study proteins at that time, for example, ‘branching morphogenesis
of an epithelial tube’ (GO:0048754) (Table S8 in File S1), ‘renal system
process’ (GO:0003014) (Tables S6–S9 in File S1), ‘glomerulus
development’ (GO:0032835) (Table S8 in File S1) and ‘ureteric bud
development’ (GO:0001657) (Table S9 in File S1). This was likely
due to lack of experimental data and/or lack of curation.
Enrichment of terms not specific to kidney
development. We noted also the appearance of GO terms
describing biological processes that are not specific to kidney
development, but are still relevant to DN. The importance of
extracellular matrix proteins in the expansion of the mesangial
matrix and thickening of basement membranes that occurs in DN
has already been reported by Abrass [49]. Although no related
terms were reported in the original analysis by Baelde et al. [29], in
the post-annotation analysis we see the terms ‘extracellular matrix
organization’ (GO:0030198) (Table S6 in File S1) and ‘basement
membrane organization’ (GO:0071711) (Table S7 in File S1)
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significantly enriched. ‘Extracellular matrix organization’
(GO:0030198) was available for annotation in 2004 but only 7
human gene products had been associated with it, none of which
were from the Baelde study set. Basement membrane-related
process terms were not added to the ontology until 2008 and so
were unavailable for use at the time of the Baelde study. Together,
this demonstrates ongoing improvements to the Gene Ontology
and GO annotations since 2004, as well as this focused annotation
project, contributed to the improved results for the post-
annotation dataset.
DN can occur due to longstanding diabetes mellitus, a
metabolic disease in which an individual has high blood sugar,
either because the body does not produce enough insulin, or
because cells do not respond to the insulin that is produced
[50,51]. Therefore it is encouraging to see the appearance of
‘positive regulation of insulin secretion involved in cellular response to glucose
stimulus’ (GO:0035774) and ‘response to insulin’ (GO:0032868) (Table
S6 in File S1) following the focused annotation.
There is increasing evidence that there is an inflammatory
aspect to DN [52] and this is reflected in the terms that were
significantly enriched in the post-annotation analysis, such as
‘inflammatory response’ (GO:0006954) (Tables S6 and S8 in File S1),
‘regulation of cytokine secretion’ (GO:0050707) (Table S6 in File S1),
‘immune system process’ (GO:0002376) and the regulation thereof
(Tables S7–S9 in File S1), ‘T cell mediated immunity’ (GO:0002456)
(Table S7 in File S1), ‘interleukin-10 production’ (GO:0032613) (Table
S7 in File S1) and ‘myeloid leukocyte activation’ (GO:0002274) (Table
S6 in File S1). The only terms relating to immunity or
inflammation in the pre-annotation dataset were ‘T cell homeostatic
proliferation’ (GO:0001777), ‘lymphocyte apoptotic process’
(GO:0070227) and ‘immune system process’ (GO:0002376) (Tables
S2 and S3 in File S1).
In general, we see only a small number of differences in GO
terms enriched for the up-regulated genes versus the down-
regulated genes. One difference was the presence of terms
describing signaling via transforming growth factor-beta and
vascular endothelial growth factor, which are known to mediate
aspects of DN. The TGF-beta signaling pathway mediates
apoptosis of endothelial cells during normal maturation of
glomerular capillaries [43]. However, in the later stages of diabetic
glomerular disease, TGF-beta1 induces fibrosis and enhances
capillary loss. Additionally, VEGF is an important mediator of
endothelial cell proliferation and one of the hallmarks of the later
stages of DN is mesangial proliferation and reduced endothelial
proliferation as a result of VEGF down-regulation. During the
early stages of DN, VEGF is up-regulated and there is active
angiogenesis with endothelial hyperproliferation. As the disease
progresses, VEGF signaling is decreased and there is a loss of
capillary action in the later stages of DN [47]. Consequently, we
observed terms involving the TGF-beta signaling pathway in the
analysis of the up-regulated set of genes, including ‘response to growth
factor’ (GO:0070848; a parent of ‘response to TGF beta’
(GO:0071559), which was also present), ‘TGF beta production’
(GO:0071604) and ‘endothelial cell apoptotic process’ (GO:0072577)
(Table S7 in File S1). Whereas in the analysis of the down-
regulated genes we observed terms involving the VEGF pathway,
such as ‘vascular endothelial growth factor (VEGF) receptor signaling
pathway’ (GO:0048010) (Tables S8 and S9 in File S1), ‘cellular
response to VEGF stimulus’ (GO:0035924) and ‘endothelial cell
proliferation’ (GO:0001935) (Table S9 in File S1). Only one of
these terms, ‘VEGF receptor signaling pathway’ (GO:0048010) was
present in the analyses using the pre-annotation dataset (Table S5
in File S1). These results suggest that genes influencing endothelial
cell proliferation may be down-regulated in DN, whereas genes
influencing endothelial cell apoptosis may be up-regulated.
A second difference between the up- and down-regulated gene
sets was the appearance of nitric oxide-type terms. One of the roles
of nitric oxide is to help control blood pressure in the kidney, so
the presence of these terms suggests that nitric oxide may play a
role in the progression of DN. It has recently been shown that
nitric oxide is reduced in diseased kidneys [53], however the
increased severity of endothelial dysfunction in DN has been
demonstrated in a mouse diabetic model, which has an endothelial
nitric oxide (eNO) synthase gene knock out [54]. We observed
terms such as ‘nitric oxide transport’ (GO:0030185) (Table S7 in File
S1) and ‘regulation of nitric oxide biosynthetic process’ (GO:0045428)
(Table S6 in File S1), only in the analysis of the up-regulated set of
genes using the post-annotation dataset.
It should be noted at this point that researchers can choose from
many freely available GO analysis tools to interpret their datasets.
However, each tool will give a different interpretation of the
dataset, as demonstrated in this paper, with the results from GO-
Elite and Ontologizer. This is usually due to the different analysis
and correction methods, statistics, filters and versions of the
ontology and annotation files that each tool integrates in order to
analyze the gene lists [55]. Nevertheless, our analyses using the
new set of ontology terms and annotations from the focused
annotation initiative, contained more specific and up-to-date
results that are in line with current knowledge about DN. This has
demonstrated that combining the published knowledge about this
distinct set of gene products together with the improved ontology
terms has greatly enhanced the interpretation of the significance of
the differentially expressed genes in DN, thus allowing us to easily
highlight the molecular processes involved in this disease.
Conclusion
We have improved the structure and content of the Gene
Ontology in the area of renal development, providing a single,
freely available resource that can be utilized beneficially by the
biomedical research community. By way of example, we
demonstrate that comprehensive annotation of a discrete set of
proteins, using the new ontology structure, can significantly
influence the interpretation of both small and large-scale data
analyses. Our work has not only improved functional annotation
for this relatively small set of proteins; during the course of this
project we have added GO annotations to almost 1000 proteins
from over 60 species. We have also laid the groundwork for
annotation of further gene products that are outside the scope of
this project; since this curation project ended in March 2012, the
522 new GO terms have been used to create almost 29,000
annotations to 12,800 distinct proteins, by manual and electronic
curation methods.
This paper highlights the importance for both continued
development of the Gene Ontology and comprehensive GO
annotation of proteins within this resource, can enable researchers
to gain improved biological insights into their particular proteins
of interest and consequently guide new investigations into
understanding the mechanisms of, and propose new treatments
for, renal diseases.
Supporting Information
File S1 File S1. includes Tables S1 to S9 presented in separate
tabs of an Excel spreadsheet, representing the input gene product
list and the output of the GO term enrichment analyses from GO-
Elite and Ontologizer Enrichment tools using the 2009 and 2012
annotation and Gene Ontology datasets for the differentially
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expressed gene products in the Baelde 2004 study. A description
tab entitled ‘Tables S2–S9 Description’, has been included,
defining the output from the GO-Elite and Ontologizer GO term
enrichment tools presented in Tables S2–S9. Table S1. Input
protein list. Mapping of the gene product identifiers
from the Baelde 2004 study to UniProtKB accession
numbers. Most of the differentially expressed gene products in
DN glomeruli were mapped to a UniProtKB accession number
and those that could not be mapped were not annotated and are
not included in the table. Table S2. GO-Elite analysis on up-
regulated proteins in DN glomeruli, using the 2009 Gene
Ontology and annotation sets. Results from the GO-Elite
enrichment analysis tool on the up-regulated proteins from the
Baelde using the Gene Ontology and Annotation files from March
2009; showing significantly enriched GO terms. The boldface
terms are referred to in the manuscript text. The ‘‘Study’’ column
shows the number of proteins in the input list with an annotation
to the given term. The ‘‘Population’’ column shows the number of
proteins in the background list with an annotation to the given
term. Table S3. Ontologizer analysis on up-regulated
proteins in DN glomeruli, using the 2009 Gene Ontology
and annotation sets. Results from the Ontologizer enrichment
analysis tool on the up-regulated proteins from the Baelde list,
using the Gene Ontology and Annotation files from March 2009;
showing significantly enriched GO terms. The boldface terms are
referred to in the manuscript text. The ‘‘Population’’ column
shows the number of proteins in the background list with an
annotation to the given term. The ‘‘Study’’ column shows the
number of proteins in the input list with an annotation to the given
term. Table S4. GO-Elite analysis on down-regulated
proteins in DN glomeruli, using the 2009 Gene Ontology
and annotation sets. Results from the GO-Elite enrichment
analysis tool on the down-regulated proteins from the Baelde list,
using the Gene Ontology and Annotation files from March 2009;
showing significantly enriched GO terms. The ‘‘Study’’ column
shows the number of proteins in the input list with an annotation
to the given term. The ‘‘Population’’ column shows the number of
proteins in the background list with an annotation to the given
term. Table S5. Ontologizer analysis on down-regulated
proteins in DN glomeruli, using the 2009 Gene Ontology
and annotation sets. Results from the Ontologizer enrichment
analysis tool on the down-regulated proteins from the Baelde list,
using the Gene Ontology and Annotation files from March 2009;
showing significantly enriched GO terms. The boldface terms are
referred to in the manuscript text. The ‘‘Population’’ column
shows the number of proteins in the background list with an
annotation to the given term. The ‘‘Study’’ column shows the
number of proteins in the input list with an annotation to the given
term. Table S6. GO-Elite analysis on up-regulated
proteins in DN glomeruli, using the 2012 Gene Ontology
and annotation sets. Results from the GO-Elite enrichment
analysis tool on the up-regulated proteins from the Baelde list,
using the Gene Ontology and Annotation files from March 2012;
showing significantly enriched GO terms. The boldface terms are
referred to in the manuscript text and the italicized boldface
indicates new terms created during the Renal GO Annotation
Initiative. The ‘‘Study’’ column shows the number of proteins in
the input list with an annotation to the given term. The
‘‘Population’’ column shows the number of proteins in the
background list with an annotation to the given term. Table
S7. Ontologizer analysis on up-regulated proteins in DN
glomeruli, using the 2012 Gene Ontology and annotation
sets. Results from the Ontologizer enrichment analysis tool on
the up-regulated proteins from the Baelde list, using the Gene
Ontology and Annotation files from March 2012; showing
significantly enriched GO terms. The boldface terms are referred
to in the manuscript text and the italicized boldface indicates new
terms created during the Renal GO Annotation Initiative. The
‘‘Population’’ column shows the number of proteins in the
background list with an annotation to the given term. The
‘‘Study’’ column shows the number of proteins in the input list
with an annotation to the given term. Table S8. GO-Elite
analysis on down-regulated proteins in DN glomeruli,
using the 2012 Gene Ontology and annotation sets.
Results from the GO-Elite enrichment analysis tool on the down-
regulated proteins from the Baelde list, using the Gene Ontology
and Annotation files from March 2012; showing significantly
enriched GO terms. The boldface terms are referred to in the
manuscript text and the italicized boldface indicates new terms
created during the Renal GO Annotation Initiative. The ‘‘Study’’
column shows the number of proteins in the input list with an
annotation to the given term. The ‘‘Population’’ column shows the
number of proteins in the background list with an annotation to
the given term. Table S9. Ontologizer analysis on down-
regulated proteins in DN glomeruli, using the 2012 Gene
Ontology and annotation sets. Results from the Ontologizer
enrichment analysis tool on the down-regulated proteins from the
Baelde list, using the Gene Ontology and Annotation files from
March 2012; showing significantly enriched GO terms. The
boldface terms are referred to in the manuscript text and the
italicized boldface indicates new terms created during the Renal
GO Annotation Initiative. The ‘‘Population’’ column shows the
number of proteins in the background list with an annotation to
the given term. The ‘‘Study’’ column shows the number of
proteins in the input list with an annotation to the given term.
(XLSX)
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